Skip to main content
OpenTrials

Clinical trial condition

Xerostomia

Explore clinical trials studying Xerostomia. Study availability and eligibility vary by location and protocol.

195 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Xerostomia trial results

Recruiting

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

NCT07621809

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +18 more
Locations
  • On Site Clinical Solutions Llc Charlotte, North Carolina, United States
  • Accurate Clinical Research League City, Texas, United States
  • Sun Valley Arthritis Center Ltd Peoria, Arizona, United States
  • Clinical Res Of W Florida Clearwater, Florida, United States
View all 14 locations
View Trial Details
Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

NCT07041099

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +16 more
Locations
  • Omega Research Orlando, Florida, United States
  • New York University Brooklyn, New York, United States
  • Regional One Memphis, Tennessee, United States
  • Stryde Research Plano, Texas, United States
View all 14 locations
View Trial Details
Recruiting

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

NCT07404865

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Arizona Arthritis & Rheumatology Associates P.C. Chandler, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates P.C. Flagstaff, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates, PLLC Glendale, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates P.C. Phoenix, Arizona, United States
View all 38 locations
View Trial Details
Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT03816345

Conditions
Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +59 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 52 locations
View Trial Details
Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT06991114

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more
Locations
  • Artiva Investigational Site Tuscaloosa Tuscaloosa, Alabama, United States
  • Artiva Investigational Site Phoenix Phoenix, Arizona, United States
  • Artiva Investigational Site Tucson Tucson, Arizona, United States
  • Artiva Investigational Site Chula Vista Chula Vista, California, United States
View all 52 locations
View Trial Details

Related conditions